Premier Biomedical, Inc. announced the addition of K. Adam Dubov to their Scientific Advisory Board effective immediately. Mr. Dubov will report to the Chairman of the Scientific Advisory Board, and co-founder of the Corporation, Dr. Mitchell S. Felder, MD, and to the President and CEO, William A. Hartman. Mr. Dubov, an FDA (Food & Drug Administration) Regulatory Expert, has extensive experience with FDA processes for all phases of clinical trials or marketing approval from the FDA.

He has been involved with both U.S. military and civilian applications related to the review and submissions for approval of clinical trials for drugs (Investigational New Drugs, Abbreviated New Drug Applications), devices (Non-Significant Risk, Investigational Device Exemptions), biologics (Biological Investigational New Drugs, and biosimilars), combination products, and other articles regulated by the FDA.